ConcertAI
AI oncology real-world evidence platform connecting clinical and genomic data to accelerate cancer drug development.
What it does
ConcertAI is an AI-native oncology real-world evidence and data intelligence platform that connects de-identified patient-level clinical data, genomic sequencing results, and treatment outcome information from health systems and cancer centers - giving pharmaceutical companies and researchers access to the real-world cancer patient data needed to design better clinical trials, identify biomarker-driven patient segments, and generate post-approval evidence for regulators and payers. AI capabilities include NLP extraction of structured cancer data from unstructured clinical notes, machine learning patient matching for clinical trial eligibility screening, AI-powered treatment outcome analysis comparing regimen effectiveness across real-world patient populations, and predictive enrollment modeling for oncology trial site selection.
Why AI-NATIVE
ConcertAI is AI-native - NLP extraction from oncology clinical notes, machine learning patient-trial matching, and AI treatment outcome analysis at scale from real-world cancer patient data are the core product capabilities.
Best for
Pharmaceutical companies, biotech firms, and academic cancer centers use ConcertAI for oncology real-world evidence - AI-extracted patient data informing trial design, biomarker discovery, and regulatory submissions.
Limitations
ConcertAI is purpose-built for oncology drug development and cancer care — pharmaceutical companies outside oncology and non-cancer therapeutic areas have limited applicable use cases.
ConcertAI's value depends on its connected health system and cancer center data network — research questions requiring patient populations outside the network cannot be answered by the platform.
Real-world evidence used in regulatory submissions requires extensive validation and expert biostatistician involvement — ConcertAI accelerates the analysis but does not eliminate regulatory expertise requirements.
Alternatives by segment
| If you need… | Consider instead |
|---|---|
| Broad real-world evidence platform | Aetion |
| Clinical trial site and patient matching | Antidote Technologies |
| Genomics and precision oncology | Tempus |
ConcertAI enterprise contracts not published. Pharmaceutical research contracts based on study scope, data access, and analysis requirements. Annual contracts.
